Creates a task force to study public health outcomes related to incurable sexually transmitted diseases
House Resolution 322 creates a legislative task force to study the public health outcomes associated with incurable sexually transmitted diseases, including hepatitis B, herpes, HIV, and HPV. The resolution frames the issue as both a public health concern and a policy question, noting Louisiana’s high rates of sexually transmitted diseases and referencing prior and proposed criminal laws related to HIV exposure and transmission. The task force is directed to examine the factors contributing to these rates and to develop recommendations for the Legislature.
The task force must be composed of representatives from the Legislature, the Louisiana Department of Health, the Louisiana Commission on HIV and Hepatitis C Education, Prevention, and Treatment, the Louisiana Coalition on Criminalization and Health, and the Louisiana District Attorneys Association. It must elect officers, meet as needed, receive staff support from the Department of Health, and report findings to the House before the 2026 Regular Session. The resolution also requires that the final report be submitted to the legislative research library.
In practical terms, the resolution does not change criminal or public health statutes directly. Instead, it creates an advisory body that may influence future legislation by gathering data, reviewing current law, and making recommendations on how Louisiana should respond to incurable sexually transmitted diseases and related criminalization issues. Its impact is therefore indirect but potentially significant for future policy development in public health and criminal justice.
The general sentiment reflected in the bill text and vote history is broadly supportive and policy-oriented. The House adopted the resolution overwhelmingly, with 81 yeas and 1 nay, suggesting strong agreement on the need for further study. The tone of the resolution emphasizes public health best practices, but it also acknowledges the criminal law context surrounding HIV exposure and transmission, indicating an effort to balance health policy with enforcement concerns.
The main point of contention is likely the relationship between public health approaches and criminalization of sexually transmitted disease transmission. The inclusion of both the Louisiana Coalition on Criminalization and Health and the District Attorneys Association on the task force signals that lawmakers expect differing views on whether criminal penalties help or hinder disease prevention and treatment. The resolution does not resolve that debate; instead, it creates a forum to study it and report back with recommendations.
HR 322 does not amend the Louisiana Revised Statutes or create new criminal penalties; it establishes a temporary task force to study public health outcomes related to incurable sexually transmitted diseases and to recommend policy changes. The resolution may influence future legislation affecting HIV exposure laws, disease transmission criminalization, public health prevention strategies, and coordination between the Department of Health, prosecutors, and advocacy groups. Its immediate legal effect is limited to creating the study body and requiring a report before the 2026 Regular Session.
The bill appears to have received strong bipartisan or near-unanimous support, as reflected in the 81-1 House vote on final consideration. The resolution’s language is framed in a public health-oriented, research-driven manner, emphasizing the need to understand why Louisiana continues to experience high STI rates and to identify best practices. The broad support suggests general agreement that the issue merits study, even if members may differ on the policy conclusions that could follow.
The likely area of disagreement is whether Louisiana should address incurable sexually transmitted diseases primarily through criminal law or through public health interventions. The resolution references existing and proposed criminal statutes involving HIV exposure and intentional infection, while also including public health advocates and prosecutors on the task force. That mix suggests tension between criminalization advocates, who may favor stronger legal penalties, and public health and civil liberties stakeholders, who may argue that punitive approaches can discourage testing, disclosure, and treatment. The resolution itself avoids taking a side and instead creates a study process to surface those competing views.